First, timely harvest to determine the harvest period of perennial forage, not only to consider the yield and quality of pasture, but also consider overwintering in favor of pasture. Under normal circumstances, the growth period of more than one month after harvest should be conducive to the safe wintering of perennial forage. Second, a reasonable height of stubble remaining stubble when harvesting the last year of the year, a direct impact on the growth rate of regenerative grass. Stay high, regeneration speed is fast, otherwise slow. The remaining height of the last rush is directly proportional to the wintering rate of the perennial pasture. However, excessive stubble will affect the grass yield of the former valerian. Therefore, the height of stubble harvested before the perennial pasture is overwintering should be between 5 and 10 cm. Third, the "Mongolia headland soil" For the ridge cultivation of perennial grass, can be used to improve the overwintering rate of forage grass. The method is to use machinery for bauxite before freezing and control the depth of the cover soil by adjusting the speed of the traction machine. Use this method should pay attention to two aspects: 1, time: generally should be carried out within 10 days before freezing. 2, cover soil depth: should be about 5 cm, too deep will affect the return of green grass in the coming year. Fourth, pouring seal frozen before pouring frozen frozen water, can improve the survival rate of overwintering pasture more than 30%. Fifth, the cover is suitable for overwinter protection of small areas of pasture. It can be adapted to local conditions. Covering about 10 cm thick straw, straw, etc., on the perennial grass planting plots, and clearing the coverings in time before returning green grasses in the next year can effectively increase the overwintering rate of pastures. Palbociclib is a drug for the treatment of ER-positive and HER2-negative breast cancer developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6.
All of our products are with stable production and strict quality control, making sure your experience with Sunshine Biotech is always enriching, satisfying and fulfilling.
Palbociclib Intermediates,Cas 571188-59-5,Cas 1013916-37-4,Cas 1016636-76-2 Nanjing Sunshine Biotech Co., Ltd , https://www.sunshine-bio.com
It was reviewed and approved under the Food and Drug Administration`s (FDA) accelerated Priority Review and Breakthrough Therapy designation programs on February 3, 2015 as a treatment (in combination with letrozole) for patients with estrogen receptor positive advanced breast cancer.
We produce a series of complete intermediates for Palbociclib, intermediate I (CAS No. 571188-59-5), intermediate II (CAS No. 1013916-37-4) and intermediate III (CAS No. 1016636-76-2) etc.
Protect pasture safely for winter
There are five main types of perennial forage pasture safety management measures commonly used: